We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$3.58B
AUM Growth
+$1.99B
Cap. Flow
+$2.1B
Cap. Flow %
58.67%
Top 10 Hldgs %
67.74%
Holding
75
New
12
Increased
27
Reduced
5
Closed
18

Top Buys

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$55.6M
2
GSM icon
FerroAtlántica
GSM
+$54.5M
3
CF icon
CF Industries
CF
+$39.8M
4
RDUS
Radius Health, Inc.
RDUS
+$39.3M
5
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$36.8M

Top Sells

Rank Stock Value
1
KRA
Kraton Corporation
KRA
+$53.3M
2
CHMA
Chiasma, Inc. Common Stock
CHMA
+$34.3M
3
TROX icon
Tronox
TROX
+$32.3M
4
TTMI icon
TTM Technologies
TTMI
+$31.4M
5
BPOP icon
Popular Inc
BPOP
+$27.3M

Sector Composition

Rank Sector Weight
1 Healthcare 9.84%
2 Industrials 6.31%
3 Financials 6.07%
4 Consumer Discretionary 6.03%
5 Materials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FREE
26
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$33.3M 0.93%
2,884,554
+184,554
+7% +$2.32M
KOP icon
27
Koppers
KOP
$858M
$33.1M 0.93%
1,059,120
+59,120
+6% +$1.84M
TRIP icon
28
TripAdvisor
TRIP
$1.23B
$31.2M 0.87%
+921,752
New +$33.1M
NVRI icon
29
Enviri
NVRI
$552M
$28.3M 0.79%
1,668,377
+778,669
+88% +$14.4M
MREO
30
Mereo BioPharma
MREO
$46.3M
$27.3M 0.76%
11,300,000
+5,639,392
+100% +$14.9M
ITOS
31
DELISTED
iTeos Therapeutics
ITOS
$26.7M 0.75%
+988,683
New +$25.8M
COOP
32
DELISTED
Mr. Cooper
COOP
$26.2M 0.73%
636,221
– –
CMRX
33
DELISTED
Chimerix, Inc.
CMRX
$24.8M 0.69%
+4,000,000
New +$27.5M
MTG icon
34
MGIC Investment
MTG
$6.27B
$22.8M 0.64%
1,521,006
– –
RDN icon
35
Radian Group
RDN
$4.87B
$21.3M 0.6%
938,368
– –
VINC
36
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$21.2M 0.59%
65,620
+38,937
+146% +$11.4M
OMF icon
37
OneMain Financial
OMF
$7.32B
$20.7M 0.58%
375,000
-34,183
-8% -$1.99M
KPTI icon
38
Karyopharm Therapeutics
KPTI
$47.1M
$19.6M 0.55%
225,051
-58,496
-21% -$6.07M
ADV icon
39
Advantage Solutions
ADV
$393M
$15.9M 0.45%
73,583
+6,041
+9% +$1.42M
MX icon
40
Magnachip Semiconductor
MX
$142M
$15.5M 0.43%
872,308
– –
CORZ
41
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$15M 0.42%
+1,486,620
New +$14.9M
IDCC icon
42
InterDigital
IDCC
$8.95B
$13.9M 0.39%
205,067
+169,889
+483% +$11.8M
HY icon
43
Hyster-Yale Materials Handling
HY
$617M
$11.1M 0.31%
221,514
– –
NFE icon
44
New Fortress Energy
NFE
$93.8M
$9.88M 0.28%
+355,840
New +$10.7M
KURA icon
45
Kura Oncology
KURA
$890M
$7.49M 0.21%
400,000
+168,519
+73% +$3.18M
KDNY
46
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$7.2M 0.2%
564,353
+238,490
+73% +$3.14M
SIOX
47
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.51M 0.18%
3,000,000
– –
SBBP
48
DELISTED
Strongbridge Biopharma plc.
SBBP
$6.27M 0.18%
3,072,732
+376,968
+14% +$877K
QSI icon
49
Quantum-Si Incorporated
QSI
$183M
$5.61M 0.16%
672,385
+179,372
+36% +$1.77M
JXN icon
50
Jackson Financial
JXN
$8.79B
$5.2M 0.15%
+200,000
New +$5.44M
1
2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2021 Portfolio in Review

As of Q3 2021, Rubric Capital Management (New York) held 75 positions worth $3.58B, up 125% from $1.59B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Rubric Capital Management (New York) deployed $2.1B of net new capital in Q3 2021, opening 12 new positions and adding to 27 existing holdings. Its largest new stake was AdaptHealth: 2,300,000 shares worth $53.6M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Ocular Therapeutix, an estimated $20.2M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2021 buy was AdaptHealth: 2,300,000 shares worth $53.6M.
  • Rubric Capital Management (New York) added most to FerroAtlántica in Q3 2021, an estimated $54.5M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2021 reduction was Ocular Therapeutix, cutting an estimated $20.2M.
  • Rubric Capital Management (New York) fully exited Kraton Corporation in Q3 2021, selling an estimated $53.3M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 68% of its $3.58B portfolio in Q3 2021.
  • Rubric Capital Management (New York) opened 12 new positions and closed 18 in Q3 2021.
  • Rubric Capital Management (New York)'s portfolio value rose 125% quarter-over-quarter to $3.58B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2021, filed 12 Nov 2021.